Concourse Financial Group Securities’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10594 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10224 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 9875 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 9650 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9424 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9188 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8970 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8626 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8634 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8451 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8299 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8112 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7876 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7513 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7201 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6916 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6678 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6448 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6291 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6192 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6102 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5949 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5953 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5845 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5758 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5602 |
|